The Effects of Glucagon-Like Peptide-1 Receptor Agonists and Dipeptydilpeptidase-4 Inhibitors on Blood Pressure and Cardiovascular Complications in Diabetes

The Effects of Glucagon-Like Peptide-1 Receptor Agonists and Dipeptydilpeptidase-4 Inhibitors on Blood Pressure and Cardiovascular Complications in Diabetes

Glucagon-like peptide-1 receptor (GLP-1R) agonists are a class of newly introduced antidiabetic medications that potentially lower blood glucose by several molecular pathways. DPP-4 inhibitors are the other type of novel antidiabetic medications which act by preventing GLP-1 inactivation and thereby...

Full description

Bibliographic Details
Main Authors: Habib Yaribeygi, Farin Rashid Farrokhi, Mohammed Altigani Abdalla, Thozhukat Sathyapalan, Maciej Banach, Tannaz Jamialahmadi, Amirhossein Sahebkar
Format: Article
Language:English
Published: Hindawi Limited 2021-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2021/6518221

Internet

http://dx.doi.org/10.1155/2021/6518221

Similar Items